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A B S T R A C T
Objective: The relationship between iron deﬁciency anemia and febrile seizures (FSs) were examined in
several studies before. The aim of our study is to ﬁnd out the differences regarding iron deﬁciency anemia,
demographic characteristics and mean platelet volume (MPV) which is an inﬂammatory marker between
simple and complex febrile seizure groups.
Methods: In this study, the authors investigated the recordings of 493 children with a diagnosis of simple
and complex febrile seizure, aged between 6 months and 6 years, followed between 2002 and 2010
retrospectively.
Results: Mean age and male/female ratio were similar in two groups. There was no signiﬁcant difference
regarding with age, gender and family history of FS between two groups. We found signiﬁcant difference
statistically with respect to gestational age, consanguinity, family history of epilepsy and birth weight
between two groups. The mean levels of Hb, Htc, MCV were lower and Plt and RDW levels were higher in
children with CFS than SFS group, the differences were statistically signiﬁcant (p: 0.001).
A higher proportion of children with CFS (16.2%) had iron deﬁciency anemia compared to SFS group
(12.1%). Mean platelet volume (MPV) of CFS (7.99  0.96 fL) were signiﬁcantly lower than that of SFS group
(8.77  0.75) (p < 0.001).
Conclusions: The results of this study suggests that iron deﬁciency anemia is more frequently seen among
the patients with CFS than the patients with SFS. The lower levels of MPV as an inﬂammatory marker,
supports the idea that CFS is a brain inﬂammatory disease and the consequence of this inﬂammatory
mechanism is the development of the epilepsy. Further studies are necessary to highlight the relationship
between iron metabolism, inﬂammation and seizures.
 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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The febrile seizure (FS) is the most frequent seizure disorder in
childhood. FSs are deﬁned as seizures that occur in association
with fever in children from 6 months to 5 years of age, with no
evidence of a central nervous system infection or other identiﬁable
causes of seizure and no history of afebrile seizures.1
Both genetic and environmental factors have been shown to
contribute to the pathogenesis of FS and generalized epilepsy with
febrile seizures plus (GEFS+); a familial epilepsy syndrome in
which patients can have classic FS, FSs that persist beyond 5 years
of age (i.e., FS+), and/or epilepsy.2 The inheritance model in FS is* Corresponding author at: Oyak sitesi 61/6 C¸ankaya, Ankara, Turkey.
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doi:10.1016/j.seizure.2011.12.014still unclear but polygenic inheritance is suspected. In large
families, the FS susceptibility trait is inherited by the autosomal
dominant pattern with reduced penetrance.3
Loci reportedly linked to FSs and GEFS+ have been identiﬁed
through analysis of large multiplex families in which the mode of
inheritance was consistent with an autosomal dominant model.
Four putative FS loci, namely FEB1 (chromosome 8q13-q21),4 FEB2
(chromosome 19p13.3),5 FEB3 (chromosome 2q23-q24)6 and FEB4
(chromosome 5q14-q15)7 have been mapped. In GEFS+ families, a
mutation in the voltage-gated sodium channel b1 subunit gene
(SCN1B)8 at chromosome 19q13.1 and 2 mutations of the same a1
subunit gene (SCN1A)9 at chromosome 2q24 were identiﬁed.The
most consistently identiﬁed risk factor for FS is the presence of a
close family history (among ﬁrst-degree relatives) of FS.10 Previous
reports have indicated an elevated risk of FS development in
children with underlying brain disorders associated with various
factors such as premature birth, delayed discharge from thevier Ltd. All rights reserved.
Table 1
The demographic characteristics of the patients with SFS and CFS.
SFS
n: 337
CFS
n: 156
p
Age (month) 38.42  32.15 34.08  21.45 0.126
Gender
Girls 123 67 0.171
Boys 214 89
Gestational age
37 week < 23 20 0.028
37 week > 314 89
Consanguinity
Absent 288 120 0.020
Present 49 36
Family history of epilepsy
Absent 316 136 0.016
Present 20 19
Family history of FC
Absent 216 106 0.403
Present 121 50
Birth weight (g) 3228.64  631.05 3078  742.20 0.021
p < 0.05, statistically signiﬁcant.
Table 2
Mean values and standard deviations of Hb, Hct, MCV, Plt, RDW and MPV among SFS
and CFS patients.
SFC
n: 337
CFC
N: 156
p
Hemoglobin 11.93  1.27 11.13  1.25 0.001
Hematocrit 35.70  3.13 33.75  3.88 0.001
MCV 75.78  5.65 73.00  6.41 0.001
Platelet 315.63  98.52 368.48  119.64 0.001
RDW 14.13  2.00 15.44  2.58 0.001
MPV 8.77  0.75 7.99  0.96 0.001
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causal link between these factors and FS has not been estab-
lished.11–14Iron deﬁciency anemia is a very common nutritional
insult among human infants, especially between 6 and 24 months.
In recent years, the number of studies investigating the relation-
ship between iron deﬁciency anemia and FS has been increasing.
Some studies support the existence of such a relationship some
do not.15–19
The structure of the brain can become abnormal because of iron
deﬁciency either in utero or in early postnatal life, because iron is
essential for proper neurogenesis, as well as for differentiation of
certain brain cells and brain regions.20–22 The hippocampus and
striatum are 2 areas of the rodent brain identiﬁed as morphologi-
cally altered in the event of iron deﬁciency. There is a decreased
arborization of dendrites that decreases the number and complex-
ity of interneuronal connections. A second morphological alter-
ation is the location and functioning of oligodendrocytes which are
responsible for producing myelin. These cells are particularly
sensitive to iron deprivation; deﬁciency results in an altered
composition and amount of myelin in the white matter. These
alterations appear to be persistent and levels do not return to
normal later in life.23,24 Published data suggest that the biology of
early developmental iron deﬁciency strongly indicates irreversible
changes in brain structure and function and that an intervention
needs to occur in the ﬁrst 6 months of postnatal life, but the
developmental trajectories for brain development are different in
rodents and humans; current studies will be able to identify critical
periods for different brain regions.25
Mean platelet volume (MPV) has been studied as a simple
inﬂammatory marker in several diseases. Some studies have
reported that MPV increases in myocardial infarction and
cerebrovascular disease, while it contrarily decreases in active
rheumatological diseases including rheumatoid arthritis (RA) and
ankylosing spondylitis (AS) and ulcerative colitis (UC).26,27
To the best of our knowledge, there is no publication reporting
the relationship between FSs and MPV levels. Our hypothesis is
simple. If epilepsy is a brain inﬂammation disorder and MPV
decreases in the inﬂammatory conditions discussed above, we
should ﬁnd lower MPV levels in the complex febrile seizure (CFS)
group compared to the simple seizure (SFS) group because CFS is a
major risk factor of epilepsy and naturally more inﬂammatory
changes occur in the brain. In our study, we compared 2 patient
groups, SFS and CFS, with respect to demographic characteristics,
iron deﬁciency anemia and MPV levels.
2. Methods
The study included 493 children with the diagnosis of febrile
seizure who were followed by the Pediatric Neurology Depart-
ment, between 2002 and 2010. Files of patients with an age ranging
between 6 months and 6 years, who were admitted to the
Emergency Service with a febrile seizure attack and then consulted
with the Pediatric Neurology Department within two weeks were
analyzed retrospectively. The patients were divided into two
groups: SFS and CFS. A single seizure of <15 min in duration in the
presence of fever without focal features was deﬁned as a simple
febrile seizure, whereas seizures were deﬁned as complex if they
lasted > 15 min, had focal features, or repeated more than once in
24 h. The ﬁrst group included 337 children and the second group
156 children. Age, sex, gestational age, birth weight, consanguinity,
family history of FS or epilepsy, and type of seizure were recorded
for all patients. The measurements of hemoglobin (Hb), hematocrit
(Hct), mean corpuscular volume (MCV), red cell distribution width
(RDW) and mean platelet volume (MPV), serum iron, total iron
binding capacity (TIBC) and ferritin levels were obtained from the
ﬁles. The blood samples were taken two weeks after the occurrenceof the seizure. Anemia was deﬁned as a decrease of the Hb and Hct
below 2 standard deviations of normal values for the age group,
with Hb at < 10.5 g% for 6–24 months and 11.5 g% for 24–72
months of age, Hct at <33% for 6–24 months and <34% for 24–72
months of age, MCV < 70 fL for 6–24 months and <75 fL for 24–72
months of age.28 Iron deﬁciency anemia was determined by
transferrin saturation of <15% and a ferritin level of <10 ng/ml.29
This study was approved by the local ethics committee.
SPSS 13.0 for Windows was used to analyze the data. Results
were expressed as mean  standard deviation. For continuous
variables, Student’s t-test was used to compare differences between
groups. The Chi-square test was used for comparison of categorical
variables. Receiver operating characteristic (ROC) curve analysis was
used to identify optimal cut-off values of the MPV level to identify CFS
with maximum sensitivity and speciﬁcity. For all tests, statistical
signiﬁcance was deﬁned as a p-value of less than 0.05.
3. Results
The mean age and male-to-female ratio were similar in the 2
groups. The demographic characteristics of the patients with SFS
and CFS are shown in Table 1.
There was no signiﬁcant difference regarding age, sex and
family history of FS between the groups. We found a signiﬁcant
statistical difference with respect to gestational age, consanguini-
ty, family history of epilepsy and birth weight between the 2
groups.
The mean levels of Hb, Hct, MCV and MPV were signiﬁcantly
lower and Plt and RDW levels were signiﬁcantly higher in children
with CFS than in those of the SFS group (p = 0.001) (Table 2).
Data for serum iron, TIBC and ferritin levels were located in the
records of 116 patients. A higher proportion of children with
CFS (25/156, 16.2%) had iron deﬁciency anemia (transferrin
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Fig. 1. ROC curve of mean platelet volume (MPV).
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group (41/337, 12.1%).
The MPV of the CFS group (7.99  0.96 fL) was signiﬁcantly lower
than that of the SFS group (8.77  0.75) (p < 0.001) (Table 2). ROC
curve analysis suggested that the optimum MPV level cut-off points
for CFS was 8.25 fL and this level can be used in the differential
diagnosis of SFS and CFS with a sensitivity and speciﬁcity of 60% and
80% respectively (AUC: 0.72) (Fig. 1).
4. Discussion
Is there a relationship between iron deﬁciency anemia and FS?
Past studies have had conﬂicting results and this is still a
controversial issue. In Turkey, the prevalence of iron deﬁciency
anemia in the children has decreased after the ‘Turkey Like Iron’
campaign by the Ministry of Health to combat iron deﬁciencies in
infants. Since 2004, daily iron supplementation of 1 mg/kg has
been given to all infants aged between 4 months and 1 year of age
but IDA still remains a common problem in Turkey.30
In our study, we had no control group because our aim was to
examine the association of seizure type (complex versus simple FS)
with Hb, MCV, RDW, MPV, and iron levels. Febrile seizures are
classiﬁed as either simple or complex according to their clinical
features, offering a limited predictive value in terms of later
recurrences or afebrile seizures. To the best of our knowledge,
there has been no prior study evaluating MPV levels as an
inﬂammation marker in the differential diagnosis of these 2
groups.
Among the numerous biological effects of iron, there is
considerable evidence that iron is also important for neurological
functions such as neurotransmitter metabolism, myelin formation
and brain energy metabolism.31 In both animal models and cell
culture experiments, there have been reproducible ﬁndings that
dopamine and norepinephrine metabolism is altered by iron
deﬁciency and only early repletion of iron status after gestational
iron deﬁciency overcomes the lasting effects.32,33 Studies involving
metabolism in the hippocampus and striatum of iron-deﬁcientrodent brain tissue suggest that fuel utilization in the iron-
deﬁcient brain is different from that in control brains.21,34 Studies
investigating the fuel utilization of the iron-deﬁcient brain of
humans have not been conducted, but the brain is the most
oxidative organ of the body and usually requires glucose as a fuel,
while it has long been known that iron deﬁciency alters glucose
homeostasis.35 The 3 aspects (morphological, biochemical and
bioenergetic) of brain biology25 impacted by iron deﬁciency are
evidence that iron is important for neurological functions and that
deﬁciencies may cause the development of febrile seizures but the
results of previous studies are conﬂicting.
Looking over the literature studies, Pisacane et al. reported a
signiﬁcantly higher rate of iron deﬁciency anemia among children
with FS than in controls. Hartﬁeld revealed that a total of 9% of
studied patients had ID and 6% had IDA compared to 5% and 4% of
controls respectively. Kobrinsky et al., in a case–control study,
showed that anemia raises the threshold for the ﬁrst FS and that iron
deﬁciency may protect against the development of febrile seizures.
Bidabadi et al. suggested that IDA was less frequent among patients
with FS as compared to the controls and that there was not a
protective effect of ID against febrile seizures.15–18 The differences
observed among these studies may be due to the differences in
ethnicities, the sample sizes of the groups, age groups and
nutritional status. In the present study, 12.1% of the SFS group
and 16% of the CFS group had IDA. The mean levels of Hb, Hct, MCV
were signiﬁcantly lower and RDW levels were signiﬁcantly higher in
children with CFS than in those of the SFS group.
A positive family history of FS among ﬁrst-degree relatives is
the most important risk factor for developing FS.36 In our study
there was no signiﬁcant difference regarding age, sex, or family
history of FS between the SFS and CFS groups, but the frequency of
a positive family history of FS for all groups was 34.1%, which is
consistent with the literature. Prematurity and low birth weights
were naturally more frequent in the CFS group, as these are risk
factors for hypoxia, sepsis, necrotizing enterocolitis triggering the
proinﬂammatory cytokines and inﬂammation; a family history of
epilepsy was also signiﬁcantly related with CFS.
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metabolism under acute phase conditions.37 Their study demon-
strated that transferrin receptor-1 (TfR1) and other iron-regulatory
proteins (hepcidin, ferritin-H, iron-regulatory protein-1 and heme
oxygenase-1) known to be expressed in the liver are also expressed
in the brain in rat model. They suggested that the induction of
cytokines in the brain might be attributable to the production of
reactive oxygen species (ROS) generated by oxidative stress as a
result of increased iron concentration, as has been observed in
other neurodegenerative disorders, or that a positive feedback
mechanism might exist that is speciﬁc for the brain, at least for
interleukin-6 (IL-6) gene expression. Dramatic changes in iron
metabolism may play a role in the development of the seizures.
Mean platelet volume is a marker of platelet function and
activation and it is also inﬂuenced by inﬂammation.38 Increased
levels of TNF-a, IL-1, IL-6 and IFN-g may be responsible for low
MPV levels in patients with CFS. Some authors argue that it is IL-6
among these mediators that is the primarily responsible cytokine
in secondary thrombocytosis.39 Our study showed that the
sensitivity and speciﬁcity of MPV in the differential diagnosis of
SFS and CFS were moderate; therefore, it is obvious that more
inﬂammatory processes occur in the brains of the patients with
CFS.
5. Conclusion
In the current study, we statistically evaluated the differences
of hematological parameters, including MPV and demonstrated a
signiﬁcant difference between the parameters in SFS and CFS
patients. Iron deﬁciency anemia is more frequently seen among
patients with CFS than in patients with SFS. We do not exactly
know whether IDA causes susceptibility to febrile seizures or not.
Decreased MPV levels are present in patients with CFS and these
results may be related to the immaturity of the hematopoietic
system in children or to active inﬂammatory states. More advanced
investigations are needed to highlight the relationships among
iron metabolism, inﬂammation and seizures.
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